Skip to content

The effect of misoprostol and oxytocin in the treatment of placenta retaining

Clinical trial of the effects of misoprostol injection compared with oxytocin injection in the umbilical vein in treatment of placenta retaining after delivery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015102824754N1
Enrollment
44
Registered
2016-05-10
Start date
2016-05-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relation the effects of misoprostol and oxytocin in the treatment of placenta.

Interventions

Intervention 1: Injection of oxytocin 50 units mixed with 30 mL of saline normal into the umbilical vein. Intervention 2: Injection of misoprostol 800 mg mixed with 30 mL of saline normal into the um
Treatment - Drugs
Injection of oxytocin 50 units mixed with 30 mL of saline normal into the umbilical vein
Injection of misoprostol 800 mg mixed with 30 mL of saline normal into the umbilical vein

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: During the first and second stages of labor with success, leaving the pair within half an hour after leaving the fetus from the uterus, to obtain written consent from patients to participate in the study Exclusion criteria: Maternal and fetal problems that lead to vaginal delivery is possible. ; Placenta within half an hour after leaving the fetus from the uterus, patient request for exclusion

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Withdrawal time of placenta. Timepoint: 30 minutes. Method of measurement: According on minutes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Hajiha

Tehran University of Medical Sciences

Neda_hajiha@yahoo.com+98 21 42460

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026